Antiestrogens – Tamoxifen, SERMs and Beyond
- 1 August 1999
- journal article
- review article
- Published by Springer Nature in Investigational New Drugs
- Vol. 17 (3), 285-311
- https://doi.org/10.1023/a:1006348907994
Abstract
Estrogens play a central role in reproductive physiology. The cellular effects of estrogens are mediated by binding to nuclear receptors (ER) which activate transcription of genes involved in...Keywords
This publication has 215 references indexed in Scilit:
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998
- Tamoxifen in the Treatment of Recurrent Ovarian CarcinomaInternational Journal of Gynecologic Cancer, 1997
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996
- Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced TranscriptionScience, 1994
- Down-regulation of transforming growth factor-α by tamoxifen in human breast cancerCancer, 1993
- Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cellsEuropean Journal Of Cancer, 1993
- Tamoxifen reduces serum insulin-like growth factor I (IGF-I)Breast Cancer Research and Treatment, 1992
- Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cells in vitroEuropean Journal Of Cancer, 1992
- Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levelsLife Sciences, 1983
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896